Get access to our best features

US regulator approves teplizumab which can delay the onset of Type 1 diabetes

Summary by Ground News
The world's first treatment which can delay the development of Type 1 diabetes has been licensed in the US.
Published 3 months ago · Washington, United States

News Articles

More Filters
All
Left
Center
Right

Game-changing type 1 diabetes drug approved in US

It is the first drug to be approved that delays the onset of the condition.

3 months ago·United Kingdom
Read Full Article

U.S. FDA greenlights Provention Bio's diabetes drug

Provention Bio said on Thursday the U.S. Food and Drug Administration had approved the use of its drug teplizumab in those aged eight years and older, the first treatment aimed at delaying the onset of insulin-dependent type 1 diabetes.

3 months ago·United Kingdom
Read Full Article

U.S. FDA approves first treatment to delay onset of type 1 diabetes

A biologic therapy that delays the onset of type 1 diabetes received approval from the U.S. Food and Drug Administration on Thursday.

3 months ago·Toronto, Canada
Read Full Article

FDA approves first treatment that delays Type 1 diabetes. Why it could be 'game changing'

A vial of TZIELD costs nearly $14,000, a notable price given the escalating cost of lifesaving insulin for people with diabetes.

3 months ago·United States
Read Full Article

FDA approves 1st drug to delay onset of Type 1 diabetes

For the first time, the U.S. Food and Drug Administration on Thursday approved a treatment that can delay the onset of Type 1 diabetes. Teplizumab, a monoclonal antibody that will be marketed under the brand name Tzield from pharmaceutical companies ProventionBio and Sanofi, is administered through intravenous infusion. The injection was shown in clinical trials to delay onset of insulin-dependent Type 1 diabetes for patients with autoantibody

3 months ago·United States
Read Full Article

FDA approves first treatment to delay onset of type 1 diabetes

A biologic therapy that delays the onset of type 1 diabetes received approval from the US Food and Drug Administration on Thursday.

3 months ago·Atlanta, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

75% of the sources are Center
CNN
USA Today
abc News
NBC News
WHDH
Koco News5
Yale University
+1
BBC News
Reuters
CTV News
The Hill
Sky News
KCRA 3
+34
Financial Post
The Hindu Business Line
The National Desk
اليوم السابع
Washington Examiner
The Epoch Times
14%
C 74%
12%
See less detail